Hypofractionated proton therapy with concurrent chemotherapy for locally advanced non-small cell lung cancer: A Phase I trial from the University of Florida and Proton Collaborative Group

We report the safety data from the first multicenter phase I trial investigating the use of hypofractionated proton therapy with concurrent chemotherapy for patients with stage II or III non-small cell lung cancer (NSCLC).

Source: International Journal of Radiation Oncology * Biology * Physics - April 2, 2020 Category: Radiology Authors: Bradford S. Hoppe, Romaine C. Nichols, Stella Flampouri, Zuofeng Li, Christopher G. Morris, Dat C. Pham, Pranshu Mohindra, William Hartsell, Nasiruddin Mohammed, Brian H. Chon, Charles B. Simone Source Type: research